These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29898750)

  • 21. Who is the average patient presenting with prostate cancer?
    Greene KL; Cowan JE; Cooperberg MR; Meng MV; DuChane J; Carroll PR;
    Urology; 2005 Nov; 66(5 Suppl):76-82. PubMed ID: 16194711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective longitudinal comparative study of health-related quality of life in patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
    Kobuke M; Saika T; Nakanishi Y; Ebara S; Manabe D; Uesugi T; Nose H; Arata R; Tsushima T; Nasu Y; Kumon H
    Acta Med Okayama; 2009 Jun; 63(3):129-35. PubMed ID: 19571899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life of patients with prostate cancer treated with surgery or radiation therapy.
    Yarbro CH; Ferrans CE
    Oncol Nurs Forum; 1998 May; 25(4):685-93. PubMed ID: 9599352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of Life After Prostate Cancer Diagnosis: Data from the Pros-IT CNR.
    Gacci M; Noale M; Artibani W; Bassi PF; Bertoni F; Bracarda S; Conti GN; Corvò R; Graziotti P; Magrini SM; Mirone V; Montironi R; Muto G; Pecoraro S; Porreca A; Ricardi U; Russi E; Tubaro A; Zagonel V; Crepaldi G; Maggi S;
    Eur Urol Focus; 2017 Oct; 3(4-5):321-324. PubMed ID: 29146557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study.
    Namiki S; Satoh T; Baba S; Ishiyama H; Hayakawa K; Saito S; Arai Y
    Urology; 2006 Dec; 68(6):1230-6. PubMed ID: 17141839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience.
    Hamstra DA; Conlon AS; Daignault S; Dunn RL; Sandler HM; Hembroff AL; Zietman AL; Kaplan I; Ciezki J; Kuban DA; Wei JT; Sanda MG; Michalski JM;
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):546-53. PubMed ID: 23561651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients' desire to preserve sexual activity and final decision for a nerve-sparing approach: results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study.
    Imbimbo C; Creta M; Gacci M; Simonato A; Gontero P; de Cobelli O; Briganti A; Fulcoli V; Martorana G; Nicita G; Mirone V; Carmignani G
    J Sex Med; 2011 May; 8(5):1495-502. PubMed ID: 21324091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.
    Jo Y; Junichi H; Tomohiro F; Yoshinari I; Masato F
    BJU Int; 2005 Jul; 96(1):43-7. PubMed ID: 15963118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-reported outcome (PRO) questionnaires for men who have radical surgery for prostate cancer: a conceptual review of existing instruments.
    Protopapa E; van der Meulen J; Moore CM; Smith SC
    BJU Int; 2017 Oct; 120(4):468-481. PubMed ID: 28437031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
    Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
    J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy.
    Truong PT; Berthelet E; Lee JC; Petersen R; Lim JT; Gaul CA; Pai H; Blood P; Ludgate CM
    Can J Urol; 2006 Jun; 13(3):3139-46. PubMed ID: 16813705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer.
    Bacon CG; Giovannucci E; Testa M; Kawachi I
    J Urol; 2001 Nov; 166(5):1804-10. PubMed ID: 11586228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease-specific quality of life among patients with localized prostate cancer: an Australian perspective.
    Newton FJ; Burney S; Millar JL; Frydenberg M; Ng KT
    BJU Int; 2006 Jun; 97(6):1179-83. PubMed ID: 16686708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.
    Madalinska JB; Essink-Bot ML; de Koning HJ; Kirkels WJ; van der Maas PJ; Schröder FH
    J Clin Oncol; 2001 Mar; 19(6):1619-28. PubMed ID: 11250990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining sexual outcomes after treatment for localized prostate carcinoma.
    Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
    Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-cultural validation of the UCLA prostate cancer index.
    Karakiewicz PI; Kattan MW; Tanguay S; Elhilali MM; Bazinet M; Scardino PT; Aprikian AG
    Urology; 2003 Feb; 61(2):302-7. PubMed ID: 12597935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline health-related quality of life in the management of prostate cancer.
    Ishihara M; Suzuki H; Akakura K; Komiya A; Imamoto T; Tobe T; Ichikawa T
    Int J Urol; 2006 Jul; 13(7):920-5. PubMed ID: 16882056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397).
    Stephens RJ; Dearnaley DP; Cowan R; Sydes M; Naylor S; Fallowfield L;
    BJU Int; 2007 Feb; 99(2):301-10. PubMed ID: 17155990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
    Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
    BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study.
    Penson DF; Feng Z; Kuniyuki A; McClerran D; Albertsen PC; Deapen D; Gilliland F; Hoffman R; Stephenson RA; Potosky AL; Stanford JL
    J Clin Oncol; 2003 Mar; 21(6):1147-54. PubMed ID: 12637483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.